Study to Investigate the Efficacy and Tolerability of AZD1446 in Adult ADHD Patients.

Adult ADHD Clinical Trial

Official title:
A Phase IIa, Multi-center, Randomized, Double-blind, Placebo-controlled, Cross-Over Study to Assess the Efficacy, Safety ,Tolerability and Pharmacokinetics of Three Oral AZD1446 Dose Regimens and Placebo During 2 Weeks of Treatment in Adult Non-Users and Users of Nicotine Containing Products

Status Completed

Clinical Trial Summary

The purpose of this study is to determine whether 2 weeks of treatment with AZD1446 compared to placebo improves ADHD symptoms and is well tolerated.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Adult ADHD

Clinical Trial Details

NCT number	NCT01012375
Study type	Interventional
Source	AstraZeneca
Contact
Status	Completed
Phase	Phase 2
Start date	November 2009
Completion date	August 2010

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03494478` - Emotional Dysregulation in Adult ADHD.	N/A
Completed	`NCT01939353` - Study of Flexible Doses of the Triple Reuptake Inhibitor EB-1020 Sustained Release (SR) in the Treatment of Adult Males With Attention-Deficit Hyperactivity Disorder	Phase 2
Active, not recruiting	`NCT03437993` - Recollect the Game: A Novel Treatment for Executive Functioning Deficits in Adults With ADHD	N/A
Active, not recruiting	`NCT06040996` - Evaluation of Improving Parenting Skills Adult ADHD (IPSA): A New Parent Training Program for Parents With ADHD	N/A
Recruiting	`NCT05832489` - EEG-MRI Imaging of Methylphenidate Effects in Adult ADHD and Attentional Symptoms in Mood Disorders	Phase 3
Completed	`NCT00318981` - Efficacy of Concerta in Treating ADHD in Mothers of Children With ADHD	Phase 4